Saturday 17 October 2026
Export AIRS’s income statement to Excel — free account
AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 2.53%, EPS fell 57.0%, free cash flow fell 131.1% and total debt fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.28
0.14
−9.86%
Follow AIRS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.18 | 0.79 | 1.29 | 2.11 | |
P/FCF ratio |
203.06 | 172.97 | 28.30 | 419.13 | |
P/Operating CF |
(2,225.53) | (47.29) | 37.29 | (257.30) | |
P/B ratio |
6.10 | 1.36 | 1.96 | 3.04 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.51 | 1.10 | 1.48 | 2.28 | |
EV/EBITDA |
0.00 | 137.01 | 285.52 | 0.00 | |
EV/Operating CF |
66.22 | 54.03 | 29.96 | 268.82 | |
EV/FCF |
223.95 | 241.75 | 32.35 | 451.69 | |
Quick Ratio |
0.37 | 0.36 | 0.57 | 0.61 | |
Current Ratio |
0.51 | 0.55 | 0.75 | 0.79 | |
Net Debt/EBITDA |
(7.88) | 23.00 | 23.07 | 8.50 | |
Debt/Assets |
30.61% | 29.92% | 23.34% | 22.54% | |
Debt/Equity |
0.69 | 0.64 | 0.45 | 0.42 | |
Asset Turnover |
0.80 | 0.76 | 0.77 | 0.77 | |
Operating CF/Net income |
0.02 | (1.97) | (2.20) | 1.11 | |
Capex/Depreciation |
(0.06) | (0.02) | (0.02) | (0.08) | |
Interest Coverage |
(6.93) | (0.68) | (1.50) | (0.03) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
55.80% | 54.47% | 57.33% | 54.59% | |
Intangible Assets out of Total Assets |
0.64 | 0.63 | 0.61 | 0.60 | |
Share Based Compensation of Revenue |
3.21% | (4.14%) | 1.42% | 2.13% | |
Graham Net Nets |
(0.18) | (0.70) | (0.34) | (0.19) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.74%) | (9.60%) | (6.01%) | (3.90%) | |
Free Cash Flow Yield |
0.49% | 0.58% | 3.53% | 0.24% | |
Revenue per Share |
0.56 | 0.55 | 0.57 | 0.61 | |
Operating CF per Share |
0.00 | (0.04) | 0.08 | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.04) | 0.08 | (0.02) | |
Cash per Share |
0.09 | 0.14 | 0.24 | 0.27 | |
Shareholders Equity per Share |
1.32 | 1.45 | 1.44 | 1.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.32 | 1.45 | 1.44 | 1.48 | |
Free Cash Flow |
(0.40) | (2.59) | 5.22 | (1.47) | |
Working Capital |
(11.94) | (12.45) | (8.15) | (7.45) | |
Capital Expenditures |
(0.18) | (0.06) | (0.05) | (0.23) | |
Net Current Asset Value |
(91.60) | (84.14) | (67.41) | (60.95) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.12 | 2.28 | 2.67 | 2.08 | |
Average Payables |
5.63 | 5.81 | 5.80 | 5.30 | |
Average Assets |
197.08 | 200.04 | 197.63 | 195.82 | |
Average Common Equity |
82.32 | 82.95 | 88.80 | 97.99 |
Columns are period end dates